FR2301258A1 - 1,3-dialcoyl-7-oxoalcoylxanthines - Google Patents

1,3-dialcoyl-7-oxoalcoylxanthines

Info

Publication number
FR2301258A1
FR2301258A1 FR7603413A FR7603413A FR2301258A1 FR 2301258 A1 FR2301258 A1 FR 2301258A1 FR 7603413 A FR7603413 A FR 7603413A FR 7603413 A FR7603413 A FR 7603413A FR 2301258 A1 FR2301258 A1 FR 2301258A1
Authority
FR
France
Prior art keywords
oxoalcoylxanthins
dialcoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7603413A
Other languages
English (en)
French (fr)
Other versions
FR2301258B1 (xx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2301258A1 publication Critical patent/FR2301258A1/fr
Application granted granted Critical
Publication of FR2301258B1 publication Critical patent/FR2301258B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7603413A 1975-02-21 1976-02-09 1,3-dialcoyl-7-oxoalcoylxanthines Granted FR2301258A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752507555 DE2507555A1 (de) 1975-02-21 1975-02-21 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
FR2301258A1 true FR2301258A1 (fr) 1976-09-17
FR2301258B1 FR2301258B1 (xx) 1978-11-17

Family

ID=5939491

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7603413A Granted FR2301258A1 (fr) 1975-02-21 1976-02-09 1,3-dialcoyl-7-oxoalcoylxanthines

Country Status (18)

Country Link
JP (1) JPS51110598A (xx)
AR (2) AR208755A1 (xx)
AT (1) AT342617B (xx)
AU (1) AU506542B2 (xx)
BE (1) BE838466A (xx)
CH (1) CH621789A5 (xx)
DE (1) DE2507555A1 (xx)
DK (1) DK72676A (xx)
ES (1) ES445301A1 (xx)
FI (1) FI760418A (xx)
FR (1) FR2301258A1 (xx)
GB (1) GB1496316A (xx)
HU (1) HU174656B (xx)
IE (1) IE43978B1 (xx)
NL (1) NL7601622A (xx)
SE (1) SE7601455L (xx)
YU (1) YU37276A (xx)
ZA (1) ZA76568B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1079267A (en) * 1964-09-05 1967-08-16 Albert Ag Chem Werke Xanthine derivatives
FR2233065A1 (xx) * 1973-06-16 1975-01-10 Hoechst Ag
FR2258183A1 (xx) * 1974-01-22 1975-08-18 Wuelfing Johann

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2761863A (en) * 1956-09-04 Lower-alkyl
DE932489C (de) * 1953-09-11 1955-09-01 Hoffmann La Roche Verfahren zur Herstellung von neuen Xanthinbasen und deren Salzen
CH325292A (de) * 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
DE1233405B (de) * 1964-09-05 1967-02-02 Albert Ag Chem Werke Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen
DE2234202A1 (de) * 1972-07-12 1974-01-24 Albert Ag Chem Werke Verfahren zur herstellung von oxoalkylxanthinen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1079267A (en) * 1964-09-05 1967-08-16 Albert Ag Chem Werke Xanthine derivatives
FR2233065A1 (xx) * 1973-06-16 1975-01-10 Hoechst Ag
FR2258183A1 (xx) * 1974-01-22 1975-08-18 Wuelfing Johann

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
EP0570831A3 (xx) * 1992-05-20 1994-03-16 Hoechst Ag

Also Published As

Publication number Publication date
YU37276A (en) 1982-08-31
NL7601622A (nl) 1976-08-24
AR208755A1 (es) 1977-02-28
AR210168A1 (es) 1977-06-30
BE838466A (fr) 1976-08-11
JPS51110598A (xx) 1976-09-30
AU1133876A (en) 1977-09-01
ATA89776A (de) 1977-08-15
HU174656B (hu) 1980-02-28
SE7601455L (sv) 1976-08-22
DE2507555A1 (de) 1976-09-02
AU506542B2 (en) 1980-01-10
IE43978L (en) 1976-08-21
AT342617B (de) 1978-04-10
DK72676A (da) 1976-08-22
FR2301258B1 (xx) 1978-11-17
GB1496316A (en) 1977-12-30
FI760418A (xx) 1976-08-22
CH621789A5 (en) 1981-02-27
ZA76568B (en) 1977-01-26
ES445301A1 (es) 1977-06-01
IE43978B1 (en) 1981-07-15

Similar Documents

Publication Publication Date Title
DK118276A (da) Glucopyranosido-1,6-mannit
BE847033A (fr) Tricots-chaines,
BE848434A (fr) Geprefabriceerd wandelement,
BE848881A (fr) Filmvormend, zonnebrand werend preparaat
BE848407A (fr) Daunosaminyl-anthracyclinones,
BE847601A (fr) Gebalanceerde tapse plugfsluiter,
SE7604095L (sv) 4,4-dihydrospiro-2h-1,3-bensoxaziner
BE848887A (fr) 7-methoxy-cephalosporines,
BE847447A (fr) 11-desoxy-16-arylprostaglandines 13-acetyleniques,
SE7609769L (sv) 1,2-bensisoxazolderivat
FR2297628A1 (fr) 2,3-dihydroergolines
NL7607985A (nl) 12-alkoxy-3,7,11-trimethyldodecatetraenen.
SE7811147L (sv) 1alfa,25-dihydrowiprevitamin dŸ3
SE7608452L (sv) 2,4-diamino-5-benzylpyrimidiner
BE849303A (fr) Tranducteur.
SE7608417L (sv) 2-klor-n-isopropyl-2',3'-dimetylacetanilid
BE844697A (fr) Ar-octahalodiphenyl-ether-4,4'-dimethanol
NL7604294A (nl) N'-sulfonyl-n"-dihalogeenfenylimidazolidinedion- -derivaten.
DK534976A (da) Substituerede 2,1,3-benzothiadiazin-forbindelser
FR2330405A1 (fr) 1'h-androsta (16,17) cyclopentene-3'-ones
FR2301258A1 (fr) 1,3-dialcoyl-7-oxoalcoylxanthines
SE7605730L (sv) Benso-2,4-tiazepiner
SE7601454L (sv) 1,3-dialkyl-7-oxoalkylxantiner
ES211713Y (es) Nueva caja-envase.
DK151559C (da) Kartonaeske.

Legal Events

Date Code Title Description
ST Notification of lapse